Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

MedSurg Income Before Taxes

MedSurg Income Before Taxes % Chg.

MedSurg Income Before Taxes Common Size

Cardiovascular Income Before Taxes

Cardiovascular Income Before Taxes % Chg.

Cardiovascular Income Before Taxes Common Size

Rhythm & Neuro Income Before Taxes

Rhythm & Neuro Income Before Taxes % Chg.

Rhythm & Neuro Income Before Taxes Common Size

Other EBT

Other EBT % Chg.

Other EBT Common Size

Total EBT

Total EBT Common Size

Total EBT % Chg.

MedSurg Organic Revenue Growth

MedSurg Organic Revenue Growth % Chg.

Rhythm & Neuro Organic Revenue Growth

Rhythm & Neuro Organic Revenue Growth % Chg.

Cardiovascular Organic Revenue Growth

Cardiovascular Organic Revenue Growth % Chg.

Total Organic Revenue Growth

Total Organic Revenue Growth % Chg.

Key Performance Indicators

Other Segment Revenue

Other Segment Revenue % Chg.

Other Segment Revenue Common Size

U.S Revenue

U.S Revenue % Chg.

U.S Revenue Common Size

Europe, Middle East and Africa Revenue

Europe, Middle East and Africa Revenue % Chg.

Europe, Middle East and Africa Revenue Common Size

Asia-Pacific Revenue

Asia-Pacific Revenue % Chg.

Asia-Pacific Revenue Common Size

Latin America and Canada Revenue

Latin America and Canada Revenue % Chg.

Latin America and Canada Revenue Common Size

Other Revenue by Geography

Other Revenue by Geography % Chg.

Other Revenue by Geography Common Size

Total Revenue by Geography

Total Revenue by Geography Common Size

Total Revenue by Geography % Chg.

Revenue by Geography

MedSurg Revenue

MedSurg Revenue % Chg.

MedSurg Revenue Common Size

Cardiovascular Revenue

Cardiovascular Revenue % Chg.

Cardiovascular Revenue Common Size

Rhythm & Neuro Revenue

Rhythm & Neuro Revenue % Chg.

Rhythm & Neuro Revenue Common Size

Other Revenue

Other Revenue % Chg.

Other Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	Sep '25	Jun '25
MedSurg Revenue	1,722	1,716
Cardiovascular Revenue	3,343	3,345
Rhythm & Neuro Revenue	—	—
Other Segment Revenue	—	—
Other Revenue	—	—
Total Revenue	5,065	5,061

Revenue by Geography	Sep '25	Jun '25
Other Segment Revenue	—	—
U.S Revenue	3,294	3,224
Europe, Middle East and Africa Revenue	793	878
Asia-Pacific Revenue	802	790
Latin America and Canada Revenue	175	169
Other Revenue by Geography	1	—
Total Revenue by Geography	5,065	5,061

EBT	Sep '25	Jun '25
MedSurg Income Before Taxes	—	—
Cardiovascular Income Before Taxes	—	—
Rhythm & Neuro Income Before Taxes	—	—
Other EBT	—	—
Total EBT	939	941

Key Performance Indicators	Sep '25	Jun '25
MedSurg Organic Revenue Growth	7.6%	7%
Rhythm & Neuro Organic Revenue Growth	—	—
Cardiovascular Organic Revenue Growth	19.4%	23.2%
Total Organic Revenue Growth	15.3%	17.4%